BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34852145)

  • 1. Persistent symptoms and decreased health-related quality of life after symptomatic pediatric COVID-19: A prospective study in a Latin American tertiary hospital.
    Fink TT; Marques HHS; Gualano B; Lindoso L; Bain V; Astley C; Martins F; Matheus D; Matsuo OM; Suguita P; Trindade V; Paula CSY; Farhat SCL; Palmeira P; Leal GN; Suzuki L; Odone Filho V; Carneiro-Sampaio M; Duarte AJS; Antonangelo L; Batisttella LR; Polanczyk GV; Pereira RMR; Carvalho CRR; Buchpiguel CA; Xavier ACL; Seelaender M; Silva CA; Pereira MFB; ; Sallum AME; Brentani AVM; Neto ÁJS; Ihara A; Santos AR; Canton APM; Watanabe A; Santos ACD; Pastorino AC; Franco BDGM; Caruzo B; Ceneviva C; Martins CCMF; Prado D; Abellan DM; Benatti FB; Smaria F; Gonçalves FT; Penteado FD; Castro GSF; Gonçalves GS; Roschel H; Disi IR; Marques IG; Castro IA; Buscatti IM; Faiad JZ; Fiamoncini J; Rodrigues JC; Carneiro JDA; Paz JA; Ferreira JC; Ferreira JCO; Silva KR; Bastos KLM; Kozu K; Cristofani LM; Souza LVB; Campos LMA; Silva Filho LVRF; Sapienza MT; Lima MS; Garanito MP; Santos MFA; Dorna MB; Aikawa NE; Litvinov N; Sakita NK; Gaiolla PVV; Pasqualucci P; Toma RK; Correa-Silva S; Sieczkowska SM; Imamura M; Forsait S; Santos VA; Zheng Y
    Clinics (Sao Paulo); 2021; 76():e3511. PubMed ID: 34852145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
    Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
    Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Dam Nielsen S; Nygaard U; Bundgaard H; Palm P; Rotvig C; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Apr; 6(4):240-248. PubMed ID: 35143771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life and functionality in primary caregiver of surviving pediatric COVID-19.
    Martins F; Gonçalves FT; Imamura M; Barboza DS; Matheus D; Pereira MFB; Marques HHS; Correa-Silva S; Montenegro MM; Fink TT; Lindoso L; Bain V; Ferreira JCOA; Astley C; Matsuo OM; Suguita P; Trindade V; Paula CSY; Litvinov N; Palmeira P; Gualano B; Delgado AF; Carneiro-Sampaio M; Forsait S; Odone-Filho V; Antonangelo L; Battistella LR; Silva CA
    Front Public Health; 2023; 11():1117854. PubMed ID: 37408752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in children and adolescents with SARS-CoV-2 infection: a cohort study in a Brazilian tertiary referral hospital.
    Marques HHS; Pereira MFB; Santos ACD; Fink TT; Paula CSY; Litvinov N; Schvartsman C; Delgado AF; Gibelli MABC; Carvalho WB; Odone Filho V; Tannuri U; Carneiro-Sampaio M; Grisi S; Duarte AJDS; Antonangelo L; Francisco RPV; Okay TS; Batisttella LR; Carvalho CRR; Brentani AVM; Silva CA; ; Eisencraft AP; Rossi Junior A; Fante AL; Cora AP; Reis AGAC; Ferrer APS; Andrade APM; Watanabe A; Gonçalves AMF; Waetge ARP; Silva CA; Ceneviva C; Lazari CDS; Abellan DM; Santos EHD; Sabino EC; Bianchini FRM; Alcantara FFP; Ramos GF; Leal GN; Rodriguez IS; Pinho JRR; Carneiro JDA; Paz JA; Ferreira JC; Ferranti JF; Ferreira JOA; Framil JVS; Silva KRD; Kanunfre KA; Bastos KLM; Galleti KV; Cristofani LM; Suzuki L; Campos LMA; Perondi MBM; Diniz MFR; Fonseca MFM; Cordon MNA; Pissolato M; Peres MS; Garanito MP; Imamura M; Dorna MB; Luglio M; Rocha MC; Aikawa NE; Degaspare NV; Sakita NK; Udsen NL; Scudeller PG; Gaiolla PVV; Severini RDSG; Rodrigues RM; Toma RK; Paula RIC; Palmeira P; Forsait S; Farhat SCL; Sakano TMS; Koch VHK; Cobello Junior V
    Clinics (Sao Paulo); 2021; 76():e3488. PubMed ID: 34852143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Palm P; Nygaard U; Bundgaard H; Petersen MNS; Rosenkilde S; Thorsted AB; Ersbøll AK; Thygesen LC; Nielsen SD; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Sep; 6(9):614-623. PubMed ID: 35752194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.
    Huang L; Yao Q; Gu X; Wang Q; Ren L; Wang Y; Hu P; Guo L; Liu M; Xu J; Zhang X; Qu Y; Fan Y; Li X; Li C; Yu T; Xia J; Wei M; Chen L; Li Y; Xiao F; Liu D; Wang J; Wang X; Cao B
    Lancet; 2021 Aug; 398(10302):747-758. PubMed ID: 34454673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New daily persistent headache after SARS-CoV-2 infection in Latin America: a cross-sectional study.
    Carrión-Nessi FS; Ascanio LC; Pineda-Arapé AG; Omaña-Ávila ÓD; Mendoza-Millán DL; Romero SR; Almao-Rivero AB; Camejo-Ávila NA; Gebran-Chedid KJ; Rodriguez-Saavedra CM; Freitas-De Nobrega DC; Castañeda SA; Forero-Peña JL; Delgado-Noguera LA; Meneses-Ramírez LK; Cotuá JC; Rodriguez-Morales AJ; Forero-Peña DA; Paniz-Mondolfi AE
    BMC Infect Dis; 2023 Dec; 23(1):877. PubMed ID: 38097988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Health-Related Quality of Life in Non-Hospitalized Coronavirus Disease 2019 (COVID-19) Cases With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in England: Longitudinal Analysis and Cross-Sectional Comparison With Controls.
    Sandmann FG; Tessier E; Lacy J; Kall M; Van Leeuwen E; Charlett A; Eggo RM; Dabrera G; Edmunds WJ; Ramsay M; Campbell H; Amirthalingam G; Jit M
    Clin Infect Dis; 2022 Aug; 75(1):e962-e973. PubMed ID: 35245941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study.
    Seeßle J; Waterboer T; Hippchen T; Simon J; Kirchner M; Lim A; Müller B; Merle U
    Clin Infect Dis; 2022 Apr; 74(7):1191-1198. PubMed ID: 34223884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months.
    Steinbeis F; Thibeault C; Doellinger F; Ring RM; Mittermaier M; Ruwwe-Glösenkamp C; Alius F; Knape P; Meyer HJ; Lippert LJ; Helbig ET; Grund D; Temmesfeld-Wollbrück B; Suttorp N; Sander LE; Kurth F; Penzkofer T; Witzenrath M; Zoller T
    Respir Med; 2022 Jan; 191():106709. PubMed ID: 34871947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe Fatigue in Long COVID: Web-Based Quantitative Follow-up Study in Members of Online Long COVID Support Groups.
    Van Herck M; Goërtz YMJ; Houben-Wilke S; Machado FVC; Meys R; Delbressine JM; Vaes AW; Burtin C; Posthuma R; Franssen FME; Hajian B; Vijlbrief H; Spies Y; van 't Hul AJ; Janssen DJA; Spruit MA
    J Med Internet Res; 2021 Sep; 23(9):e30274. PubMed ID: 34494964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended coagulation profile of children with Long Covid: a prospective study.
    Di Gennaro L; Valentini P; Sorrentino S; Ferretti MA; De Candia E; Basso M; Lancellotti S; De Cristofaro R; De Rose C; Mariani F; Morello R; Lazzareschi I; Sigfrid L; Munblit D; Buonsenso D
    Sci Rep; 2022 Nov; 12(1):18392. PubMed ID: 36319840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2.
    Molteni E; Sudre CH; Canas LS; Bhopal SS; Hughes RC; Antonelli M; Murray B; Kläser K; Kerfoot E; Chen L; Deng J; Hu C; Selvachandran S; Read K; Capdevila Pujol J; Hammers A; Spector TD; Ourselin S; Steves CJ; Modat M; Absoud M; Duncan EL
    Lancet Child Adolesc Health; 2021 Oct; 5(10):708-718. PubMed ID: 34358472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
    Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM
    Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of SARS-CoV-2 Seropositivity With Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany.
    Sorg AL; Becht S; Jank M; Armann J; von Both U; Hufnagel M; Lander F; Liese JG; Niehues T; Verjans E; Wetzke M; Stojanov S; Behrends U; Drosten C; Schroten H; von Kries R
    JAMA Netw Open; 2022 Sep; 5(9):e2233454. PubMed ID: 36166227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.